Found 0 matching trials
Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients PHASE4 Measles is a vaccine-preventable disease, which can be life-threatening in ...
Show More Location
Children's Hospital of Geneva
Learn More & Join Trial
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis PHASE4 Background:
The safety of vaccination in patients with autoimmune diseases...
Show More Location
Academic hospital Maastricht
Learn More & Join Trial
Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine PHASE3 Follow-up to evaluate the immunogenicity and safety of three production lot...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination PHASE3 Primary Series Primary objectives
* To demonstrate that the concomitant ad...
Show More Location
Sanofi Pasteur MSD Investigational Site 003
Learn More & Join Trial
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants PHASE2 Open-label, single-arm trial, Primary Objectives included:
1. To assess th...
Show More Location
Queen Sirikit National Institute of Child Health
Learn More & Join Trial
Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella PHASE2 Measles and rubella are highly contagious acute viral diseases. As per WHO,...
Show More Location
Centro de Estudos e Pesquisas em Moléstias Infecciosas Ltda (CPCLIN)
Learn More & Join Trial
Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) PHASE3 The primary objectives of this study are to evaluate the immunogenicity and...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers PHASE3 The primary objective of this study is to demonstrate the non-inferiority o...
Show More Location
Alabama Clinical Therapeutics Site Number : 8400036
Treatments Being Tested
Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine Haemophilus b Conjugate Vaccine Pneumococcal 13-valent Conjugate Vaccine Rotavirus Vaccine, Live, Oral, Pentavalent Hepatitis B Vaccine Measles, Mumps, and Rubella Virus Vaccine Live Varicella Virus Vaccine Live Learn More & Join Trial
Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups N/A Achieving optimal vaccination rates is vital for protecting the health and ...
Show More Location
Boston Medical Center
Learn More & Join Trial
A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines PHASE2 The purpose of this study is to investigate the potential for co-administra...
Show More Location
Multiple Locations
Treatments Being Tested
Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus OKAVAX®:Attenuated live varicella-zoster virus and AVAXIM® 80U: Hepatitis A virus Vaccines Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and Childhood vaccines Live, attenuated, recombinant dengue serotypes 1, 2, 3 and 4 virus and NaCl (Placebo) Learn More & Join Trial